Vanda Pharmaceuticals (VNDA) Cash from Operations (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Cash from Operations of 50218000.0 in Q1 2026, down 70.71% quarter-over-quarter from 29417000.0 in Q4 2025, and down 51.5% year-over-year from 103544168.08 in Q1 2025.
Vanda Pharmaceuticals' Cash from Operations history runs 17 years deep, the most recent figure standing at 50218000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 51.5% year-over-year to 50218000.0; the TTM figure through Mar 2026 stood at 126513000.0 (down 124.02% YoY), while the FY2025 annual figure was 109442000.0, down 594.56% from the prior year.
- Cash from Operations came in at 50218000.0 for Q1 2026 at Vanda Pharmaceuticals, down from 29417000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 31803000.0 in Q1 2023 to a low of 50218000.0 in Q1 2026.
- A 5-year average of 7684235.29 and a median of 3732000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations jumped 686.04% in 2023 and slumped 1518.99% in 2025, its largest moves.
- Vanda Pharmaceuticals' Cash from Operations stood at 9416000.0 in 2022, then sank by 139.63% to 3732000.0 in 2023, then soared by 51.31% to 1817000.0 in 2024, then plunged by 1518.99% to 29417000.0 in 2025, then tumbled by 70.71% to 50218000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 50218000.0, 29417000.0, and 31626000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -50.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.22 Mn |
| Mar 31, 2026 | -50.22 Mn |
| Dec 31, 2025 | -29.42 Mn |
| Dec 31, 2025 | -29.42 Mn |
| Sep 30, 2025 | -31.63 Mn |
| Sep 30, 2025 | -31.63 Mn |
| Jun 30, 2025 | -15.25 Mn |
| Jun 30, 2025 | -15.25 Mn |
| Mar 31, 2025 | -33.15 Mn |
| Mar 31, 2025 | -33.15 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | -14.58 Mn |
| Sep 30, 2024 | -14.58 Mn |
| Jun 30, 2024 | -6.93 Mn |
| Jun 30, 2024 | -6.93 Mn |
| Mar 31, 2024 | 7.57 Mn |
| Mar 31, 2024 | 7.57 Mn |
| Dec 31, 2023 | -3.73 Mn |
| Dec 31, 2023 | -3.73 Mn |
| Sep 30, 2023 | -2.05 Mn |
| Sep 30, 2023 | -2.05 Mn |
| Jun 30, 2023 | -13.22 Mn |
| Jun 30, 2023 | -13.22 Mn |
| Mar 31, 2023 | 31.80 Mn |
| Mar 31, 2023 | 31.80 Mn |
| Dec 31, 2022 | 9.42 Mn |
| Dec 31, 2022 | 9.42 Mn |
| Sep 30, 2022 | 12.84 Mn |
| Sep 30, 2022 | 12.84 Mn |
| Jun 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 5.69 Mn |
| Mar 31, 2022 | 4.05 Mn |
| Mar 31, 2022 | 4.05 Mn |
| Dec 31, 2021 | 26.61 Mn |
| Dec 31, 2021 | 26.61 Mn |
| Sep 30, 2021 | 9.40 Mn |
| Sep 30, 2021 | 9.40 Mn |
| Jun 30, 2021 | 19.02 Mn |
| Jun 30, 2021 | 19.02 Mn |
| Mar 31, 2021 | 9.19 Mn |
| Mar 31, 2021 | 9.19 Mn |
| Dec 31, 2020 | 19.30 Mn |
| Dec 31, 2020 | 19.30 Mn |
| Sep 30, 2020 | 9.37 Mn |
| Sep 30, 2020 | 9.37 Mn |
| Jun 30, 2020 | 24.01 Mn |
| Jun 30, 2020 | 24.01 Mn |
| Mar 31, 2020 | -907,000.00 |
| Mar 31, 2020 | -907,000.00 |
| Dec 31, 2019 | 9.79 Mn |
| Dec 31, 2019 | 9.79 Mn |
| Sep 30, 2019 | 6.00 Mn |
| Sep 30, 2019 | 6.00 Mn |
| Jun 30, 2019 | 20.52 Mn |
| Jun 30, 2019 | 20.52 Mn |
| Mar 31, 2019 | 9.64 Mn |
| Mar 31, 2019 | 9.64 Mn |
| Dec 31, 2018 | 15.26 Mn |
| Dec 31, 2018 | 15.26 Mn |
| Sep 30, 2018 | 8.69 Mn |
| Sep 30, 2018 | 8.69 Mn |
| Jun 30, 2018 | 4.39 Mn |
| Jun 30, 2018 | 4.39 Mn |
| Mar 31, 2018 | 1.64 Mn |
| Mar 31, 2018 | 1.64 Mn |
| Dec 31, 2017 | 3.47 Mn |
| Dec 31, 2017 | 3.47 Mn |
| Sep 30, 2017 | 2.17 Mn |
| Sep 30, 2017 | 2.17 Mn |
| Jun 30, 2017 | -2.26 Mn |
| Jun 30, 2017 | -2.26 Mn |
| Mar 31, 2017 | -5.36 Mn |
| Mar 31, 2017 | -5.36 Mn |
| Dec 31, 2016 | -1.18 Mn |
| Dec 31, 2016 | -1.18 Mn |
| Sep 30, 2016 | 1.24 Mn |
| Sep 30, 2016 | 1.24 Mn |
| Jun 30, 2016 | -3.26 Mn |
| Jun 30, 2016 | -3.26 Mn |
| Mar 31, 2016 | -4.90 Mn |
| Mar 31, 2016 | -4.90 Mn |
| Dec 31, 2015 | -356,000.00 |
| Dec 31, 2015 | -356,000.00 |
| Sep 30, 2015 | -4.85 Mn |
| Sep 30, 2015 | -4.85 Mn |
| Jun 30, 2015 | 12.10 Mn |
| Jun 30, 2015 | 12.10 Mn |
| Mar 31, 2015 | 5.56 Mn |
| Mar 31, 2015 | 5.56 Mn |
| Dec 31, 2014 | -13.39 Mn |
| Dec 31, 2014 | -13.39 Mn |
| Sep 30, 2014 | -7.60 Mn |
| Sep 30, 2014 | -7.60 Mn |
| Jun 30, 2014 | -36.67 Mn |
| Jun 30, 2014 | -36.67 Mn |
| Mar 31, 2014 | -23.90 Mn |
| Mar 31, 2014 | -23.90 Mn |
| Dec 31, 2013 | -12.15 Mn |
| Dec 31, 2013 | -12.15 Mn |
| Sep 30, 2013 | -10.27 Mn |
| Sep 30, 2013 | -10.27 Mn |
| Jun 30, 2013 | -8.04 Mn |
| Jun 30, 2013 | -8.04 Mn |
| Mar 31, 2013 | -9.13 Mn |
| Mar 31, 2013 | -9.13 Mn |
| Dec 31, 2012 | -13.85 Mn |
| Dec 31, 2012 | -13.85 Mn |
| Sep 30, 2012 | -10.16 Mn |
| Sep 30, 2012 | -10.16 Mn |
| Jun 30, 2012 | -12.21 Mn |
| Jun 30, 2012 | -12.21 Mn |
| Mar 31, 2012 | -8.69 Mn |
| Mar 31, 2012 | -8.69 Mn |
| Dec 31, 2011 | -12.36 Mn |
| Dec 31, 2011 | -12.36 Mn |
| Sep 30, 2011 | -7.17 Mn |
| Sep 30, 2011 | -7.17 Mn |
| Jun 30, 2011 | -5.62 Mn |
| Jun 30, 2011 | -5.62 Mn |
| Mar 31, 2011 | -3.26 Mn |
| Mar 31, 2011 | -3.26 Mn |
| Dec 31, 2010 | -5.10 Mn |
| Dec 31, 2010 | -5.10 Mn |
| Sep 30, 2010 | -5.07 Mn |
| Sep 30, 2010 | -5.07 Mn |